Render Target: SSR
Render Timestamp: 2024-11-14T23:08:13.275Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-30 01:58:53.298
Product last modified at: 2024-09-30T08:02:17.998Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

TRMT6 (E7L3M) Rabbit mAb #18791

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H R Mk
    SENSITIVITY Endogenous
    MW (kDa) 62
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • R-Rat 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    TRMT6 (E7L3M) Rabbit mAb recognizes endogenous levels of total TRMT6 protein.

    Species Reactivity:

    Human, Rat, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro333 of human TRMT6 protein.

    Background

    TRMT6 and TRMT61A, formerly known as GCD10 and GCD14 in yeast, are essential, conserved proteins that form a heterodimer responsible for N1-methylation (m1A) of adenosine 58 in tRNA (1-4). TRMT6 is an RNA-binding protein that recognizes target substrates, while TRMT61A binds AdoMet to catalyze the methylation event (4). TRMT6/61A can additionally produce the m1A mark in small RNAs such as tRNA-derived fragments (tRFs) and also in mRNAs, though in much lower abundance (5,6). The heterodimeric complex is localized to stress granules during heat shock and provides protection for the transcriptome (7). TRMT6 has shown to play a role in progression of malignant gliomas (8). Disruption of the heterodimer has been shown to negatively affect T cell expansion in mice (9).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    XP is a registered trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.